Valuation: Becton, Dickinson and Company

Market Cap 4.21TCr 3.71TCr 3.44TCr 3.17TCr 5.94TCr 4,08200Cr 6.05TCr 41TCr 16TCr 1,99100Cr 16TCr 15TCr 6,90700Cr P/E 2026 *
38.1x
P/E 2027 * 29.4x
Enterprise Value 5.87TCr 5.16TCr 4.79TCr 4.41TCr 8.27TCr 5,68100Cr 8.42TCr 57TCr 22TCr 2,77100Cr 22TCr 22TCr 9,61300Cr EV / Sales 2026 *
3.05x
EV / Sales 2027 * 2.84x
Free-Float
74.04%
Yield 2026 *
2.52%
Yield 2027 * 2.56%
1 day-0.12%
1 week-4.35%
Current month+1.08%
1 month+6.29%
3 months-1.21%
6 months-24.19%
Current year-21.18%
1 week 151.97
Extreme 151.97
158.27
1 month 147.2
Extreme 147.2
163.14
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
286.46
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Compliance Officer - 01/02/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Date Insider Type Main position Quantity % Market Cap.
02/07/26 Tax

Executive/Senior Manager

-1,935 0.0007%
26/06/26 Sell

Executive/Senior Manager

-75 0.0000%
24/06/26 Sell

Executive/Senior Manager

-1,100 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.12%-4.35%-16.22%-42.24% 4.21TCr
+0.18%+1.94%-19.93%-11.85% 18TCr
+0.15%-1.85%-10.87%-7.81% 10TCr
+1.49%-0.95%+3.96%+58.40% 5.94TCr
-1.13%-2.60%+26.37%+54.76% 5.07TCr
+1.21%-8.47% - - 3.18TCr
-1.33%-9.62%-18.45%-46.03% 2.72TCr
-0.82%-1.92%+56.39%-5.79% 2.51TCr
+0.03%-4.74%-6.58%-9.24% 2.05TCr
+0.30%-4.54%-16.61%-2.81% 1.94TCr
Average +0.02%-3.30%-0.22%-1.40% 5.57TCr
Weighted average by Cap. +0.18%-1.54%-6.27%-0.15%

Financials

2026 *2027 *
Net sales 1.92TCr 1.69TCr 1.57TCr 1.44TCr 2.71TCr 1,86100Cr 2.76TCr 19TCr 7.32TCr 91TCr 7.21TCr 7.06TCr 3,14900Cr 1.97TCr 1.73TCr 1.61TCr 1.48TCr 2.78TCr 1,91000Cr 2.83TCr 19TCr 7.52TCr 93TCr 7.41TCr 7.25TCr 3,23200Cr
Net income 112.46Cr 99Cr 92Cr 85Cr 158.49Cr 11TCr 161.33Cr 1.1TCr 428.59Cr 5.31TCr 422.21Cr 413.08Cr 18TCr 144.92Cr 127.46Cr 118.41Cr 108.9Cr 204.23Cr 14TCr 207.89Cr 1.42TCr 552.28Cr 6.85TCr 544.07Cr 532.3Cr 24TCr
Net Debt 1.65TCr 1.45TCr 1.35TCr 1.24TCr 2.33TCr 1,59900Cr 2.37TCr 16TCr 6.29TCr 78TCr 6.2TCr 6.07TCr 2,70600Cr 1.4TCr 1.23TCr 1.14TCr 1.05TCr 1.97TCr 1,35200Cr 2TCr 14TCr 5.32TCr 66TCr 5.24TCr 5.13TCr 2,28700Cr
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
23/26/23 $152.97 -0.12% 16,07,955
22/26/22 $153.16 -0.44% 11,62,418
21/26/21 $153.84 -0.41% 13,32,536
20/26/20 $154.48 -2.33% 17,30,130
17/26/17 $158.17 -1.10% 21,08,792
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
152.97USD
Average target price
179.36USD
Spread / Average Target
+17.25%

Quarterly revenue - Rate of surprise